Work

Abstract LB268: Preclinical development of 3H-10000, a novel vedotin antibody-drug conjugate for treatment of FGFR2b-expressing cancers

Year: 2026

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2026-lb268

Authors: Mingming Gao, Susan Liuchen, Jufang Lin, Bingshuang Xu, Yan Ding, Qiaoxin Zeng, Zhixiong Zhang, Li Cao, Chunzhe Guo, Tao Liu, Ning Jiao, Yong Peng, Shaojing Hu

Language: English

Topic: Monoclonal and Polyclonal Antibodies Research

Subfield: Radiology, Nuclear Medicine and Imaging

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7154706866

Cites:

Cited by: 1

Related to: